isradipine has been researched along with Cardiovascular Pregnancy Complications in 9 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isradipine lowered the maternal mean arterial blood pressure effectively in women with nonproteinuric hypertension but did not do so in women with proteinuria at recruitment or appearing during treatment." | 9.08 | Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. ( Andersson, KE; Forman, A; Ingemarsson, I; Lindberg, B; Lindeberg, S; Lunell, NO; Marsàl, K; Skajaa, K; Wide-Swensson, DH, 1995) |
| "Fourteen women with hypertension of pregnancy and who were in their last trimester were subjected to three standardized physical stress tests before and after 1-2 weeks of treatment with 5 mg of isradipine twice daily." | 9.07 | Effect of isradipine on responses to standardized physical stress tests in hypertension of pregnancy. ( Grunewald, C; Lunell, NO; Nisell, H, 1992) |
| "9 years) who had developed hypertension (blood pressure greater than 140/90 mm Hg) took part in an open pilot study with the new calcium antagonist isradipine." | 9.07 | Influence of isradipine on the maternal and fetal cardiovascular system in hypertensive disorders in pregnancy. ( Feiks, A; Grünberger, W; Meisner, W, 1991) |
| "To determine the appropriate dosage regimen of isradipine in black patients with severe hypertension of pregnancy, 10 patients (gestational age, 30 to 38 weeks; diastolic blood pressure [DBP], 110 to 148 mm Hg; no hypertensive crises; and normal central venous pressure) were given an isradipine infusion while the fetal heart rate was continuously recorded using a cardiotocograph." | 7.69 | Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study. ( Khedun, SM; Madhanpall, N; Maharaj, B; Moodley, J; van der Byl, K, 1994) |
| " This pilot study was conducted to determine the appropriate dosage regimen for isradipine in black patients with severe hypertensive disorders of pregnancy." | 5.29 | Intravenous isradipine in the management of severe hypertension of pregnancy in black patients: a pilot study. ( Khedun, SM; Madhanpall, N; Maharaj, B; Moodley, J; van der Byl, K, 1994) |
| "Isradipine lowered the maternal mean arterial blood pressure effectively in women with nonproteinuric hypertension but did not do so in women with proteinuria at recruitment or appearing during treatment." | 5.08 | Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. ( Andersson, KE; Forman, A; Ingemarsson, I; Lindberg, B; Lindeberg, S; Lunell, NO; Marsàl, K; Skajaa, K; Wide-Swensson, DH, 1995) |
| "Fourteen women with hypertension of pregnancy and who were in their last trimester were subjected to three standardized physical stress tests before and after 1-2 weeks of treatment with 5 mg of isradipine twice daily." | 5.07 | Effect of isradipine on responses to standardized physical stress tests in hypertension of pregnancy. ( Grunewald, C; Lunell, NO; Nisell, H, 1992) |
| "9 years) who had developed hypertension (blood pressure greater than 140/90 mm Hg) took part in an open pilot study with the new calcium antagonist isradipine." | 5.07 | Influence of isradipine on the maternal and fetal cardiovascular system in hypertensive disorders in pregnancy. ( Feiks, A; Grünberger, W; Meisner, W, 1991) |
| "To determine the appropriate dosage regimen of isradipine in black patients with severe hypertension of pregnancy, 10 patients (gestational age, 30 to 38 weeks; diastolic blood pressure [DBP], 110 to 148 mm Hg; no hypertensive crises; and normal central venous pressure) were given an isradipine infusion while the fetal heart rate was continuously recorded using a cardiotocograph." | 3.69 | Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study. ( Khedun, SM; Madhanpall, N; Maharaj, B; Moodley, J; van der Byl, K, 1994) |
| "To assess the effect of isradipine on blood pressure, and uteroplacental and fetal blood flows in pregnancy-induced hypertension, 41 women with a diastolic blood pressure greater than or equal to 95 mm Hg were included in our study." | 3.68 | Isradipine, a new calcium antagonist: effects on maternal and fetal hemodynamics. ( Garoff, L; Grunewald, C; Lunell, NO; Nisell, H; Nylund, L; Sarby, B; Thornström, S, 1991) |
| " This pilot study was conducted to determine the appropriate dosage regimen for isradipine in black patients with severe hypertensive disorders of pregnancy." | 1.29 | Intravenous isradipine in the management of severe hypertension of pregnancy in black patients: a pilot study. ( Khedun, SM; Madhanpall, N; Maharaj, B; Moodley, J; van der Byl, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darcie, S | 1 |
| Leone, CR | 1 |
| Calil, VM | 1 |
| Prescinotti, EP | 1 |
| Kahhale, S | 1 |
| Zugaib, M | 1 |
| Wide-Swensson, DH | 1 |
| Ingemarsson, I | 2 |
| Lunell, NO | 4 |
| Forman, A | 1 |
| Skajaa, K | 1 |
| Lindberg, B | 1 |
| Lindeberg, S | 1 |
| Marsàl, K | 1 |
| Andersson, KE | 1 |
| Maharaj, B | 2 |
| Khedun, SM | 2 |
| Moodley, J | 2 |
| Madhanpall, N | 2 |
| van der Byl, K | 2 |
| Bondesson, U | 1 |
| Grunewald, C | 3 |
| Nisell, H | 3 |
| Wide-Swensson, D | 1 |
| Maher, MJ | 1 |
| Dworkin, LD | 1 |
| Garoff, L | 1 |
| Nylund, L | 1 |
| Sarby, B | 1 |
| Thornström, S | 1 |
| Feiks, A | 1 |
| Grünberger, W | 1 |
| Meisner, W | 1 |
1 review available for isradipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Calcium antagonists in the treatment of hypertension: special clinical considerations.
Topics: Angina Pectoris; Angina, Unstable; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; | 1996 |
5 trials available for isradipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Glycemia in newborns of hypertensive mothers according to maternal treatment.
Topics: Antihypertensive Agents; Apgar Score; Atenolol; Blood Glucose; Epidemiologic Methods; Female; Fetal | 2004 |
Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Hear | 1995 |
Transplacental passage of isradipine in the treatment of pregnancy-induced hypertension.
Topics: Amniotic Fluid; Delayed-Action Preparations; Female; Fetal Blood; Humans; Hypertension; Isradipine; | 1993 |
Effect of isradipine on responses to standardized physical stress tests in hypertension of pregnancy.
Topics: Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Exercise Test; Female; Heart Rate; Human | 1992 |
Influence of isradipine on the maternal and fetal cardiovascular system in hypertensive disorders in pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Fetus; Hea | 1991 |
3 other studies available for isradipine and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study.
Topics: Adolescent; Adult; Black People; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Inj | 1994 |
Intravenous isradipine in the management of severe hypertension of pregnancy in black patients: a pilot study.
Topics: Adolescent; Adult; Black People; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rat | 1994 |
Isradipine, a new calcium antagonist: effects on maternal and fetal hemodynamics.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Fetus; Heart Rate; Heart | 1991 |